logo
Plus   Neg
Share
Email

Frontier IP: Exscientia To Get Up To €240 Mln In AI-based Drug Deal With Bayer

Frontier IP Group Plc announced Friday that Artificial Intelligence- driven drug discovery company Exscientia has entered into a collaboration with Bayer AG (BAYZF.PK,BAYRY.PK,BYR.L) focused on cardiovascular disease and oncology.

Under the deal terms, Exscientia will initially work on three projects with targets agreed between both parties.

Exscientia may be eligible to receive up to 240 million euros including upfront and research payments, and for meeting near term and clinical milestones. The company may also receive sales royalties.

Joerg Moeller, Member of the Executive Committee of Bayer AG's Pharmaceuticals Division and Head of Research and Development said, "We are driving forward digital transformation in R&D as we believe that digital technologies such as AI can simplify and speed up the discovery and development of new drugs for patients. The collaboration with Exscientia is expected to help us to achieve project milestones earlier and at the same time accelerate timelines by enabling more precise identification of suitable drug targets and lead structures."

Exscientia's other partnerships include collaborations with Celgene, GSK, Roche, Sanofi, GT Apeiron, Rallybio and Evotec.

Frontier IP currently holds a 3.25 percent stake in the company.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
California-based Sierra Soups is recalling "Pasta e Fagioli" soup mix for concerns of undeclared gluten, the U.S. Food and Drug Administration said in a statement. The soup mix contained an individually wrapped package of pasta that contains gluten, a known allergen. However, the outer packaging states the product is Gluten Free. The problem was caused by a breakdown in the packaging processes. McDonald's unveils Golden Shamrock Shake to commemorate the 50th anniversary of its Shamrock Shake. Six days after the return of the popular, mint-flavored shake, McDonald's Tuesday announced it is auctioning off a jewel-and-diamond-encrusted 18-karat gold cup, called the Golden Shamrock Shake, with... Walt Disney Co. (DIS) Tuesday announced CEO Robert Iger will step down immediately, and will be replaced by Bob Chapek. Chapek most recently served as Chairman of Disney Parks, Experiences and Products. Iger will assume the role of Executive Chairman and will "direct the company's creative endeavors,"...
Follow RTT
>